Regeneron Pharmaceuticals, Inc.
Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

Abstract:

The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to a coronavirus spike protein and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., coronavirus infections).